Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis (GMCSFSbv)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00973128
Recruitment Status : Completed
First Posted : September 9, 2009
Last Update Posted : September 9, 2009
Sponsor:
Collaborator:
Fundação de Amparo à Pesquisa do Estado da Bahia
Information provided by:
Hospital Universitário Professor Edgard Santos

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2006
Actual Study Completion Date : May 2007